Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
JAMA Oncol ; 4(6): e173598, 2018 06 14.
Artículo en Inglés | MEDLINE | ID: mdl-29121177

RESUMEN

Importance: Oral anticancer medications are increasingly important but costly treatment options for patients with cancer. By early 2017, 43 states and Washington, DC, had passed laws to ensure patients with private insurance enrolled in fully insured health plans pay no more for anticancer medications administered by mouth than anticancer medications administered by infusion. Federal legislation regarding this issue is currently pending. Despite their rapid acceptance, the changes associated with state adoption of oral chemotherapy parity laws have not been described. Objective: To estimate changes in oral anticancer medication use, out-of-pocket spending, and health plan spending associated with oral chemotherapy parity law adoption. Design, Setting, and Participants: Analysis of administrative health plan claims data from 2008-2012 for 3 large nationwide insurers aggregated by the Health Care Cost Institute. Data analysis was first completed in 2015 and updated in 2017. The study population included 63 780 adults living in 1 of 16 states that passed parity laws during the study period and who received anticancer drug treatment for which orally administered treatment options were available. Study analysis used a difference-in-differences approach. Exposures: Time period before and after adoption of state parity laws, controlling for whether the patient was enrolled in a plan subject to parity (fully insured) or not (self-funded, exempt via the Employee Retirement Income Security Act). Main Outcomes and Measures: Oral anticancer medication use, out-of-pocket spending, and total health care spending. Results: Of the 63 780 adults aged 18 through 64 years, 51.4% participated in fully insured plans and 48.6% in self-funded plans (57.2% were women; 76.8% were aged 45 to 64 years). The use of oral anticancer medication treatment as a proportion of all anticancer treatment increased from 18% to 22% (adjusted difference-in-differences risk ratio [aDDRR], 1.04; 95% CI, 0.96-1.13; P = .34) comparing months before vs after parity. In plans subject to parity laws, the proportion of prescription fills for orally administered therapy without copayment increased from 15.0% to 53.0%, more than double the increase (12.3%-18.0%) in plans not subject to parity (P < .001). The proportion of patients with out-of-pocket spending of more than $100 per month increased from 8.4% to 11.1% compared with a slight decline from 12.0% to 11.7% in plans not subject to parity (P = .004). In plans subject to parity laws, estimated monthly out-of-pocket spending decreased by $19.44 at the 25th percentile, by $32.13 at the 50th percentile, and by $10.83 at the 75th percentile but increased at the 90th ($37.19) and 95th ($143.25) percentiles after parity (all P < .001, controlling for changes in plans not subject to parity). Parity laws did not increase 6-month total spending for users of any anticancer therapy or for users of oral anticancer therapy alone. Conclusions and Relevance: While oral chemotherapy parity laws modestly improved financial protection for many patients without increasing total health care spending, these laws alone may be insufficient to ensure that patients are protected from high out-of-pocket medication costs.


Asunto(s)
Antineoplásicos/economía , Gastos en Salud/estadística & datos numéricos , Beneficios del Seguro/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Honorarios por Prescripción de Medicamentos/legislación & jurisprudencia , Administración Oral , Adolescente , Adulto , Antineoplásicos/administración & dosificación , Utilización de Medicamentos/economía , Femenino , Planes de Seguro con Fines de Lucro/economía , Planes de Seguro con Fines de Lucro/legislación & jurisprudencia , Planes de Asistencia Médica para Empleados/economía , Planes de Asistencia Médica para Empleados/legislación & jurisprudencia , Humanos , Infusiones Intravenosas , Beneficios del Seguro/economía , Aseguradoras , Cobertura del Seguro/economía , Cobertura del Seguro/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/economía , Masculino , Persona de Mediana Edad , Honorarios por Prescripción de Medicamentos/estadística & datos numéricos , Puntaje de Propensión , Estados Unidos , Adulto Joven
2.
Fed Regist ; 69(4): 1083-267, 2004 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-14968797

RESUMEN

This interim final rule implements the provisions of the Medicare Prescription Drug, Improvement, and Modernization Act (MPDIMA) of 2003, Pub. L. 108-173, which are applicable in 2004 to Medicare payment for covered drugs and physician fee schedule services. These provisions revise the current payment methodology for Part B covered drugs and biologicals that are not paid on a cost or prospective payment basis; make changes to Medicare payment for furnishing or administering drugs and biologicals; revise the geographic practice cost indices and change the physician fee schedule conversion factor. The 2004 physician fee schedule conversion factor will be $37.3374. The 2004 national anesthesia conversion factor (prior to making adjustment for the geographic practice cost indices) will be $17.4969. The information contained in this final rule related to payment under the physician fee schedule supercedes the information contained in the November 7, 2003, final rule to the extent that the two are inconsistent. All other provisions of the November 7, 2003, final rule are unchanged unless otherwise noted. This rule also extends the "opt-out" provisions of 1802(b)(5)(3) of the Social Security Act to dentists, podiatrists, and optometrists.


Asunto(s)
Tabla de Aranceles/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Medicare Part B/legislación & jurisprudencia , Sistema de Pago Prospectivo/legislación & jurisprudencia , Centers for Medicare and Medicaid Services, U.S. , Tabla de Aranceles/economía , Humanos , Seguro de Servicios Farmacéuticos/economía , Legislación de Medicamentos , Medicare Part B/economía , Sistema de Pago Prospectivo/economía , Estados Unidos
3.
Fed Regist ; 66(28): 9651-8, 2001 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-11503862

RESUMEN

This interim final rule implements several sections of the Floyd D. Spence National Defense Authorization Act for Fiscal Year 2001. The rule allows coverage of physical examinations for beneficiaries ages 5 through 11 that are required in connection with school enrollment; provides an additional two-year period for survivors of deceased active-duty members to remain eligible for TRICARE medical and dental benefits at active-duty dependent rates; extends eligibility for medical and dental benefits to Medal of Honor recipients and their immediate dependents in the same manner as if the recipient were entitled to retired pay; partially implements the Pharmacy Benefits Program establishing revised copays and cost-shares for the prescription drug benefit; implements the TRICARE Senior Pharmacy Program by establishing a new eligibility for prescription drug benefits for Medicare-eligible retirees; allows a waiver of copayments, cost-shares, and deductibles for all Uniformed Services TRICARE eligible active duty family members residing with their TRICARE Prime Remote eligible Active Duty Service Member Sponsor within a TRICARE Prime Remote designated area until implementation of the TRICARE Prime Remote for Family Member Program or October 30, 2001, whichever is later; provides for the elimination of TRICARE Prime copayments for active duty family members enrolled in TRICARE Prime; provides for the reimbursement of reasonable travel expenses for TRICARE Prime beneficiaries referred by a primary care provider to a specialty care provider who provides services over 100 miles away; and reduces the maximum amount which retirees, their family members and survivors would be liable from $7,500 to $3,000. The Department is publishing this rule as an interim final rule in order to meet statutorily required effective dates. Public comments, however, are invited and will be considered as to possible revisions to this rule.


Asunto(s)
Planes de Asistencia Médica para Empleados , Beneficios del Seguro , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Niño , Preescolar , Seguro de Costos Compartidos/economía , Seguro de Costos Compartidos/legislación & jurisprudencia , Determinación de la Elegibilidad , Planes de Asistencia Médica para Empleados/economía , Planes de Asistencia Médica para Empleados/legislación & jurisprudencia , Humanos , Beneficios del Seguro/economía , Beneficios del Seguro/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/economía , Medicina Militar/economía , Estados Unidos
4.
Health Prog ; 75(7): 24-9, 1994 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10136075

RESUMEN

In 1993, responding to a $5.7 billion deficit among the country's third-party payers, the German parliament imposed mandatory global budgets for physician, hospital, dental, and pharmaceutical services. Although Germany had been able to maintain health spending at a lower rate than the United States, an excessive supply of health resources was beginning to drive prices higher. During the three years the global budgets are in place, German third-party payers (the "sickness funds") and providers will implement several fundamental reforms. These include: Reducing excessive supply of specialists Constraining the acquisition and utilization of expensive medical technologies Reducing the annual number of physician visits per person Reducing average hospital length of stay Integrating community- and hospital-based physician services Reducing payroll deductions for mandated benefits The 1993 reforms also impose a budgetary cap at the 1991 expenditure level for drugs prescribed by community-based physicians. In addition, the reforms call for the implementation of community-rated premiums and stipulate that Germans be able to select their sickness fund each year. Although the reforms make important changes, they leave the basic German healthcare system intact. It is difficult to imagine, moreover, that any of the reforms being implemented will in the foreseeable future place any major element of the health system in serious financial peril; in fact, they will help preserve the system.


Asunto(s)
Reforma de la Atención de Salud/economía , Gastos en Salud/legislación & jurisprudencia , Seguro de Salud/economía , Presupuestos/legislación & jurisprudencia , Estudios de Evaluación como Asunto , Alemania , Reforma de la Atención de Salud/legislación & jurisprudencia , Seguro de Salud/legislación & jurisprudencia , Seguro de Hospitalización/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Seguro de Servicios Médicos/legislación & jurisprudencia , Método de Control de Pagos/legislación & jurisprudencia
5.
Pediatrics ; 114(1): e37-42, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15231971

RESUMEN

OBJECTIVE: Twenty-three million people, accounting for >58% of Medicaid enrollees, are enrolled in Medicaid managed care programs. Although the expectation of management in Medicaid managed care programs necessitates restrictions in use of some services sought by patients and families, the circumstances surrounding care denial and related access problems in vulnerable populations of children have not been studied. The objective of this study was to identify experiences with care denial reported by families in TennCare, Tennessee's managed care program for Medicaid enrollees and uninsured. METHODS: Primary caregivers for 399 children who were enrolled in TennCare and presented for care at 21 pediatric and family medicine sites throughout Tennessee participated in a face-to-face interview. RESULTS: Of the 399 caregivers who participated in the study, 146 (36.6%) reported that their child experienced denial of care in the previous 12 months at a physician's office (12.5% of those interviewed), dentist's office (13.8%), or pharmacy (20.0%). For denial of any 1 type of care, families of children with chronic conditions (multivariable odds ratio [OR]: 2.05; 95% confidence interval [CI]: 1.41-2.99) and those whose parents had >12 years of education (OR: 1.80; CI: 1.21-2.70) were more likely to report denial of care; families of black children were less likely to report denial than white children (OR: 0.34; CI: 0.20-0.56). Content analysis of caregiver perceptions identified provider concerns about reimbursement as a factor in denials. Of the children who could not be seen by a physician, caregivers perceived that 12.2% became sicker as a result of the delay in care; 16.3% reported an emergency department visit after the denial. CONCLUSIONS: More than one third of TennCare families reported denials of care for their children in the previous year, and factors surrounding these denials were identified. Given the large number of Americans who receive health care through Medicaid managed care programs like TennCare, more research is needed to understand the implications of denied care for children and families who are enrolled in these programs.


Asunto(s)
Programas Controlados de Atención en Salud , Medicaid , Negativa al Tratamiento/estadística & datos numéricos , Planes Estatales de Salud , Adolescente , Análisis de Varianza , Cuidadores , Niño , Preescolar , Enfermedad Crónica/terapia , Femenino , Encuestas de Atención de la Salud , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Humanos , Lactante , Cobertura del Seguro , Reembolso de Seguro de Salud , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Masculino , Tennessee , Estados Unidos
6.
Artículo en Inglés | MEDLINE | ID: mdl-14969254

RESUMEN

Medicaid provides health care insurance for low-income children, some parents who meet income thresholds, pregnant women, the elderly and the disabled. In order to receive federal funds for Medicaid, each state must offer coverage for the following health care services: inpatient and outpatient hospital services; physician services; medical and surgical dental services; nursing facility services; home health care services; family planning services; rural health clinic services; laboratory and x-ray services; pediatric and family nurse practitioner services; federally qualified health center services; nurse-midwife services; and early and periodic screening, diagnosis and treatment (EPSDT) services for individuals under age 21. States can also choose to cover certain additional services under their Medicaid plans, and these often include prescription drugs, dental services (nonmedical or surgical), clinic services, and vision and hearing services. It is up to each state to decide what optional services to include with the mandated services to create their Medicaid benefit package.


Asunto(s)
Beneficios del Seguro/legislación & jurisprudencia , Medicaid/legislación & jurisprudencia , Predicción , Política de Salud/legislación & jurisprudencia , Política de Salud/tendencias , Humanos , Beneficios del Seguro/tendencias , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/tendencias , Medicaid/tendencias , Gobierno Estatal , Estados Unidos
7.
Artículo en Inglés | MEDLINE | ID: mdl-12877158

RESUMEN

Medicaid provides health care insurance for low-income children, some parents who meet income thresholds, pregnant women, the elderly and the disabled. In order to receive federal funds for Medicaid, each state must offer coverage for the following health care services: inpatient and outpatient hospital services; physician services; medical and surgical dental services; nursing facility services; home health care services; family planning services; rural health clinic services; laboratory and x-ray services; pediatric and family nurse practitioner services; federally qualified health center services; nurse-midwife services; and early and periodic screening, diagnosis and treatment (EPSDT) services for individuals under age 21. States can also choose to cover certain additional services under their Medicaid plans, and these often include prescription drugs, dental services (nonmedical or surgical), clinic services, and vision and hearing services. It is up to each state to decide what optional services to include with the mandated services to create their Medicaid benefit package.


Asunto(s)
Política de Salud/legislación & jurisprudencia , Beneficios del Seguro/legislación & jurisprudencia , Cobertura del Seguro/legislación & jurisprudencia , Medicaid/legislación & jurisprudencia , Gobierno Estatal , Adulto , Anciano , Niño , Femenino , Predicción , Política de Salud/economía , Política de Salud/tendencias , Humanos , Beneficios del Seguro/economía , Beneficios del Seguro/tendencias , Cobertura del Seguro/economía , Cobertura del Seguro/tendencias , Seguro de Servicios Farmacéuticos/economía , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/tendencias , Masculino , Medicaid/economía , Medicaid/tendencias , Embarazo , Atención no Remunerada/economía , Atención no Remunerada/legislación & jurisprudencia , Atención no Remunerada/tendencias , Estados Unidos
9.
Artículo en Inglés | MEDLINE | ID: mdl-18345573

Asunto(s)
Seguro de Salud , Medicaid , Adulto , Benchmarking/economía , Benchmarking/legislación & jurisprudencia , Niño , Servicios de Salud del Niño/economía , Servicios de Salud del Niño/legislación & jurisprudencia , Quiropráctica/legislación & jurisprudencia , Servicios de Salud Comunitaria/economía , Servicios de Salud Comunitaria/legislación & jurisprudencia , Atención Odontológica/legislación & jurisprudencia , Servicios de Planificación Familiar/economía , Servicios de Planificación Familiar/legislación & jurisprudencia , Gobierno Federal , Servicios de Atención de Salud a Domicilio/economía , Servicios de Atención de Salud a Domicilio/legislación & jurisprudencia , Cuidados Paliativos al Final de la Vida/economía , Cuidados Paliativos al Final de la Vida/legislación & jurisprudencia , Humanos , Seguro de Salud/economía , Seguro de Salud/legislación & jurisprudencia , Seguro de Servicios Farmacéuticos/economía , Seguro de Servicios Farmacéuticos/legislación & jurisprudencia , Cuidados a Largo Plazo/economía , Cuidados a Largo Plazo/legislación & jurisprudencia , Medicaid/economía , Medicaid/legislación & jurisprudencia , Servicios de Salud Mental/economía , Servicios de Salud Mental/legislación & jurisprudencia , Cese del Hábito de Fumar/economía , Cese del Hábito de Fumar/legislación & jurisprudencia , Gobierno Estatal , Estados Unidos , Servicios de Salud para Mujeres/economía , Servicios de Salud para Mujeres/legislación & jurisprudencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA